2 documents found, page 1 of 1
Applicability of EU(7)-PIM criteria in cross-national studies in European count...
Fialova, D; Brkic, J; Laffon, B; Reissigova, J; Gresakova, S; Dogan, S; Doro, P; Tasic, L; Marinkovic, V; Valdiglesias, V; Costa, S; Kostriba, JBackground: The European Union (EU)(7)-PIM (potentially inappropriate medication) list presents the most comprehensive and up-to-date tool for evaluation of PIM prescribing in Europe; however, several country-specific studies have documented lower specificity of this list on pharmaceutical markets of some countries. The aim of our study was to describe approval rates and marketing of PIMs stated by EU(7)-PIM cr...
Medication use in older patients and age-blind approach: narrative literature r...
Fialová, D; Laffon, B; Marinković, V; Tasić, L; Doro, P; Sόos, G; Mota, J; Dogan, S; Brkić, J; Teixeira, JP; Valdiglesias, V; Costa, SIntroduction The importance of rational drug therapy is increasing with the aging of the population. Since one of the main reasons for inappropriate drug prescribing is also the “age-blind” approach, which results in ageist practices, this narrative literature review focuses on the description of the main barriers related to insufficient individualization of drug regimens associated with such age-blind approach...